Jul 22, 2026 · 9 min · 6 segments
How does discontinuing beta-blockers after MI affect outcomes in patients without HF? Dan Atar and C. Michael Gibson break it down.
Dan AtarGuest
C. Michael GibsonHostHi, I'm Mike Gibson, Dr. Dan Attar, and we're coming to you live from ESC 2025, and we're talking about your trial randomizing patients to discontinuation of beta blockers in the setting of MI.
Hi, I'm Mike Gibson, Dr. Dan Attar, and we're coming to you live from ESC 2025, and we're talking about your trial randomizing patients to discontinuation of beta blockers in the setting of MI.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.
